Prof. Clement Furlong | biochemistry | Best Researcher Award

Posted on by sciencefatherLeave a Comment on Prof. Clement Furlong | biochemistry | Best Researcher Award

Prof. Clement Furlong | biochemistry | Best Researcher Award 🏆

Professor, Depts. Medicine & Genome Sciences at  University of Washington,United States🎓

Clement E. Furlong, PhD, a distinguished researcher in the fields of biochemistry and molecular biology, has made significant contributions through his extensive education and experience. With a Ph.D. from the University of California, Davis, and postdoctoral training at Cornell University, Dr. Furlong has held several prominent positions at the University of Washington, shaping the landscape of medical genetics and toxicology. His research primarily focuses on paraoxonases, their role in neurotoxicity, and their implications for public health, particularly in relation to environmental exposures.

Professional Profile 

🎓 Education

Dr. Clement E. Furlong obtained his B.A. in Chemistry from San Jose State College in 1963, followed by a Ph.D. in Biochemistry from the University of California, Davis, in 1968. He completed a PHS Postdoctoral Fellowship in Biochemistry and Molecular Biology at Cornell University from 1968 to 1970 and underwent sabbatical training in immunology at Stanford University from 1976 to 1977.

🏢 Work Experience

Dr. Furlong began his academic career as an Assistant Professor of Biochemistry at the University of California, Riverside (1970-1975), advancing to Associate Professor before transitioning to the University of Washington, where he held several prominent positions including Research Associate Professor, Research Professor, and currently serves as a Professor of Medicine in the Division of Medical Genetics and Genome Sciences since 2011. He also holds an Adjunct Professor role in the Department of Environmental and Occupational Health Sciences and is a Research Affiliate at the UW Center on Human Development and Disability.

🧬 Skills

Dr. Furlong is highly skilled in biochemistry, molecular biology, and toxicology, with a focus on paraoxonases and their role in neurotoxicity. His extensive background in research, mentorship, and training equips him to guide students and colleagues effectively.

Awards and Honors 🏆

Throughout his career, Dr. Furlong has received numerous accolades, including B.A. Honors in Chemistry, memberships in Sigma Xi, and multiple U.S. Public Health Service fellowships. He was awarded the Paper of the Year Award from the Journal of Human and Ecological Risk Assessment in 2002.

Memberships📜 

Dr. Furlong is an active member of professional organizations such as the Society of Toxicology and Sigma Xi, contributing to the advancement of research in toxicology and biochemistry.

📚 Teaching Experience

As a dedicated educator, Dr. Furlong has taught courses in Genome Sciences and Environmental Health. He has mentored numerous undergraduate and graduate students, guiding them through their research projects and thesis work.

🔬 Research Focus

Dr. Furlong’s research primarily centers on the biochemical and molecular mechanisms of environmental exposure and its effects on human health. His work on paraoxonases aims to elucidate their role in modulating neurotoxicity and susceptibility to diseases, particularly in the context of neurotoxic exposures and genetic factors.

Conclusion 

In conclusion, Clement E. Furlong, PhD, exemplifies the qualities of an outstanding researcher suitable for the Best Researcher Award. His extensive education, significant contributions to the field of biochemistry and molecular biology, and dedication to mentoring emerging scientists position him as a leader in his field. By addressing opportunities for public engagement and interdisciplinary collaboration, Dr. Furlong can enhance the impact of his already impressive body of work, making him an exemplary candidate for this esteemed award.

📚 Publilcation 

  • PON1 Status in Relation to Gulf War Illness: Evidence of Gene–Exposure Interactions from a Multisite Case–Control Study of 1990–1991 Gulf War Veterans
    • Year: 2024
    • Journal: International Journal of Environmental Research and Public Health
  • Examining the role of paraoxonase 2 in the dopaminergic system of the mouse brain
    • Year: 2022
    • Journal: BMC Neuroscience
  • Paraoxonase 2 deficiency in mice alters motor behavior and causes region-specific transcript changes in the brain
    • Year: 2021
    • Journal: Neurotoxicology and Teratology
  • Paraoxonase-1 (PON1) Status Analysis Using Non-Organophosphate Substrates
    • Year: 2021
    • Journal: Current Protocols

Joanna Bartkowiak-Wieczorek | Pharmacology | Best Researcher Award

Posted on by sciencefatherLeave a Comment on Joanna Bartkowiak-Wieczorek | Pharmacology | Best Researcher Award

Dr. Joanna Bartkowiak-Wieczorek | Pharmacology | Best Researcher Award 🏆

Poznan University of Medical Sciences, Poland🎓

Dr.Joanna Bartkowiak-Wieczorek is an accomplished researcher and Assistant Professor at the Medical University of Karol Marcinkowski in Poznań, specializing in pharmacology and pharmacogenetics. With a strong focus on cannabinoids and their potential medical applications, particularly in oncology and personalized medicine, she has contributed significantly to understanding how genetic factors influence drug response. Joanna’s work has been recognized with the Best Researcher Award, reflecting her dedication to advancing pharmacological research and education. She is committed to bridging the gap between scientific inquiry and clinical practice, enhancing the safety and efficacy of pharmacotherapy for diverse patient populations.

 

Professional Profile 

 

🎓 Education

Joanna Bartkowiak-Wieczorek holds a Master of Science in Biological Sciences from Adam Mickiewicz University in Poznań, specializing in molecular biology. She completed her PhD at the Medical University of Poznań, focusing on epigenetic modifications in hybrids of green frogs and the polymorphism of genes associated with osteoporosis risk.

🏢 Work Experience

Since September 2018, she has served as an Assistant Professor at the Medical University of Karol Marcinkowski in Poznań, where she conducts research and teaches various programs in human physiology. Prior to this, she worked as scientific and technical staff at the Medical University of Poznań, conducting pharmacogenetic research and educational classes. She also held roles focused on quality management systems at the Institute of Natural Fibres and Medicinal Plants, contributing to the implementation of GMP and ISO standards.

 

Awards and Honors 🏆

Joanna has participated in various research projects funded by the National Science Centre, focusing on pharmacogenetics and the development of technologies for cannabinoid extraction for cancer treatment. Her contributions to scientific knowledge have been recognized through numerous publications in reputable journals, reflecting her commitment to advancing research in her field.

🔬 Research Focus

Joanna’s research primarily explores cannabinoids, their pharmacological properties, and applications in oncology and personalized medicine. She has conducted significant studies on the influence of individual genes on drug responses and has a strong background in pharmacogenetics, drug interactions, and the therapeutic potential of plant-based compounds.

Conclusion 

Joanna’s qualifications and achievements position her as a leading figure in her field, making her a suitable candidate for the Best Researcher Award. By addressing the identified areas for improvement, she could further enhance her research impact and continue to contribute to advancements in pharmacology and personalized medicine.

📚 Publilcation 

  1. Bartkowiak-Wieczorek, J., et al. (2024). Cannabis sativa L. Extract Alleviates Neuropathic Pain and Modulates CB1 and CB2 Receptor Expression in Rat. Biomolecules. DOI: 10.3390/biom14091065
  2. Bartkowiak-Wieczorek, J., et al. (2024). Methylsulfinyl Hexyl Isothiocyanate (6-MSITC) from Wasabi: A Promising Candidate for Cancer, Alzheimer’s Disease, and Obesity Treatment. Nutrients. DOI: 10.3390/nu16152509
  3. Bartkowiak-Wieczorek, J., et al. (2024). The Dual Faces of Oestrogen: The Impact of Exogenous Oestrogen on Physiological and Pathophysiological Functions of Tissues and Organs. International Journal of Molecular Sciences. DOI: 10.3390/ijms25158167
  4. Bartkowiak-Wieczorek, J., et al. (2024). Natural Products and Health. Nutrients. DOI: 10.3390/nu16030415
  5. Bartkowiak-Wieczorek, J. (2023). A Critical Look at New Possibilities of Therapeutic Use of Statins: A Summary of Current Knowledge. Farmacja Polska. DOI: 10.32383/farmpol/174070
  6. Bartkowiak-Wieczorek, J., et al. (2023). THC-Reduced Cannabis sativa L.—How Does the Solvent Determine the Bioavailability of Cannabinoids Given Orally?. Nutrients. DOI: 10.3390/nu15122646
  7. Bartkowiak-Wieczorek, J., et al. (2022). The Dark Side of Iron: The Relationship Between Iron, Inflammation, and Gut Microbiota in Diseases Associated with Iron Deficiency Anaemia. Nutrients. DOI: 10.3390/nu14173478
  8. Bartkowiak-Wieczorek, J. (2022). Polygraph Analyses: Technical and Practical Background. Journal of Medical Science. DOI: 10.20883/medical.e590
  9. Bartkowiak-Wieczorek, J., et al. (2021). High-Fat, Western-Style Diet, Systemic Inflammation, and Gut Microbiota: A Narrative Review. Cells. DOI: 10.3390/cells10113164
  10. Bartkowiak-Wieczorek, J., et al. (2020). Relationship Between Adipocytokines and Angiotensin-Converting Enzyme Gene Polymorphism in Lean Women with and without Polycystic Ovary Syndrome. Gynecological Endocrinology. DOI: 10.1080/09513590.2019.1695248
  11. Bartkowiak-Wieczorek, J., et al. (2020). Effect of Different Water Extracts from Platycodon grandiflorum on Pathogenesis of Chronic Bronchitis in Rats. Molecules. DOI: 10.3390/molecules25215020
  12. Bartkowiak-Wieczorek, J., et al. (2020). Effect of Genetic Variations for Interleukin-10 on Efficacy of Immunosuppressive Therapy in Kidney Transplant Patients. International Immunopharmacology. DOI: 10.1016/j.intimp.2020.107059
  13. Bartkowiak-Wieczorek, J. (2020). The MDR1/ABCB1 Gene Polymorphism in Colorectal Cancer. Archives of Medical Science. DOI: 10.5114/aoms.2017.70329
  14. Bartkowiak-Wieczorek, J., et al. (2019). Effect of MDR1 and CYP3A41B Polymorphisms on Cyclosporine-Based Immunosuppressive Therapy in Renal Transplant Patients*. Annals of Transplantation. DOI: 10.12659/AOT.914683
  15. Bartkowiak-Wieczorek, J. (2018). Demographic Factors Determining Folic Acid Supplementation in Pregnant and Childbearing-Age Women. Ginekologia Polska. DOI: 10.5603/GP.a2018.0036
  16. Bartkowiak-Wieczorek, J. (2018). Effect of Interleukin-6 Polymorphism on Renal Allograft Function and Immunosuppressive Therapy Efficacy. Farmacia. DOI: 10.31925/farmacia.2018.5.8
  17. Bartkowiak-Wieczorek, J., et al. (2018). Importance of New Generation Sequencing HLA Typing in Renal Transplantation—Preliminary Report. Transplantation Proceedings. DOI: 10.1016/j.transproceed.2018.05.005
  18. Bartkowiak-Wieczorek, J., et al. (2017). Effect of Salvia miltiorrhiza Root Extract on Brain Acetylcholinesterase, Butyrylcholinesterase Activities, mRNA Levels, and Memory in Rats. Physiology and Behavior. DOI: 10.1016/j.physbeh.2017.02.019
  19. Bartkowiak-Wieczorek, J. (2017). Role of the ITLN1 Gene Allelic Variant in Patients with Diabetic Foot. Polish Archives of Internal Medicine. DOI: 10.20452/pamw.4008
  20. Bartkowiak-Wieczorek, J., et al. (2017). Polymorphic Variants of Collagen 1A2 Gene in Osteopenia and Osteoporosis Development in Postmenopausal Women. Ginekologia Polska. DOI: 10.5603/GP.A2017.0077
  21. Bartkowiak-Wieczorek, J., et al. (2016). Analysis of Aldosterone Synthase and Atrial Natriuretic Peptide Gene Polymorphisms in Women with Preeclampsia. European Journal of Obstetrics and Gynecology and Reproductive Biology. DOI: 10.1016/j.ejogrb.2015.11.012
  22. Bartkowiak-Wieczorek, J. (2016). Association Between ACE Gene Polymorphism and Metabolic Disturbances in PCOS Women. Molecular Medicine Reports. DOI: 10.3892/mmr.2016.5910
  23. Bartkowiak-Wieczorek, J., et al. (2016). Influence of Melissa officinalis Leaf Extract on Long-Term Memory in Scopolamine Animal Model. Evidence-Based Complementary and Alternative Medicine. DOI: 10.1155/2016/9729818
  24. Bartkowiak-Wieczorek, J. (2016). Association Between Metabolic Syndrome Development in PCOS Patients and MTHFR Gene Polymorphism. Ginekologia Polska. DOI: 10.17772/gp/61751
  25. Bartkowiak-Wieczorek, J., et al. (2016). Antinociceptive and Anti-Inflammatory Effects of Oleanolic Acid and Aspirin Conjugate. Frontiers in Pharmacology. DOI: 10.3389/fphar.2016.00202
  26. Bartkowiak-Wieczorek, J. (2016). Importance of MDR1 Gene Polymorphisms in Colorectal Cancer Etiology. Przegląd Gastroenterologiczny. DOI: 10.5114/pg.2015.51185
  27. Bartkowiak-Wieczorek, J., et al. (2016). Influence of TNF-α Polymorphism on Immunosuppressive Therapy Efficacy in Kidney Transplant Patients. Journal of Physiology and Pharmacology.
  28. Bartkowiak-Wieczorek, J. (2016). Significance of Genetic Polymorphisms in the RANKL/RANK/OPG Signaling Pathway in Postmenopausal Osteoporosis. Ginekologia Polska. DOI: 10.5603/GP.2016.0014
  29. Bartkowiak-Wieczorek, J., et al. (2015). Analysis of ADIPOQ Gene Polymorphisms in Women with Excessive Weight Gain During Pregnancy. Ginekologia Polska. DOI: 10.17772/gp/2421
  30. Bartkowiak-Wieczorek, J., et al. (2015). Evaluation of Anti-Inflammatory and Analgesic Activities of Extracts from Chelidonium majus L. Herb. Central European Journal of Immunology. DOI: 10.5114/ceji.2015.54607
  31. Bartkowiak-Wieczorek, J. (2015). *Gender-Specific Implications for Pharmacology in Women of Child